Abstract:Background: Atherosclerosis (AS) is a vascular disease which causes cardiovascular diseases such as stroke, heart attack and acute coronary syndrome. It is a major cause of death worldwide, especially in developed countries. In AS, the artery walls become thickened due to the accumulation and invasion of white blood cells (foam cells) and form a fibro-fatty plaque. Hence, these investigations aim to identify the potential applications of herbal compounds targeting the AMPK signalling pathway for AS therapy.Methods: In this investigation, in vitro kinase activity was determined for a set of herbal compounds present in herbal plants and herbal medicines against 5' AMP-activated protein kinase (AMPK). This enzyme plays a vital role in AS, having an effect on the invasion and accumulation of white blood cells, leading to the thickening of artery walls and vascular remodelling. In addition, a molecular docking simulation study was carried out for the AMPK enzyme (PDB ID: 3AQV) against the herbal compounds.Results: The in vitro kinase activity showed that 10 of the herbal compounds possessed IC50 values lower than 10 mu M, which showed the potent inhibitory effect of the AMPK enzyme. In addition, a molecular docking simulation carried out on the AMPK enzyme (PDB ID: 3AQV) against the herbal compounds observed a positive correlation with IC50 values and docking scores of the docked compounds with an IC50 <10 mu M. The subsequent protein- ligand interaction analyses for the best docking hits showed favourable interactions. Also, the molecular dynamics simulation enabled the generation of a trajectory file for the RMSD backbone, illustrating the stability of the docked protein- ligand complex without any structural fluctuations.Conclusions: The study concludes that baicalin, curcumin, campesterol, emodin and gingerol provide a promising lead for AS and can therefore be prescribed for the treatment of AS.

Discovery of natural adenosine monophosphate‐activated protein kinase activators through virtual screening and activity verification studies

In Silico Analysis of AMP-activated Protein Kinase and Ligand-based Virtual Screening for Identification of Novel AMPK Activators.

Targeting AMPK signalling pathway with natural medicines for atherosclerosis therapy: an integration of in silico screening and in vitro assay

Discovery of Oral AMP-Activated Protein Kinase Activators for Treating Hyperlipidemia

In Silico Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes.

Modeling Structure–Activity Relationship of AMPK Activation

Computer-aided drug design for AMP-activated protein kinase activators.

Computational screening and QSAR analysis for design of AMP-activated protein kinase agonist

Drug Design for AMP-Activated Protein Kinase Agonists in Silico

Study of Amp-Activated Protein Kinase Agonists by Structure-Based Drug Designing

The Discovery of Novel Vascular Endothelial Growth Factor Receptor Tyrosine Kinases Inhibitors: Pharmacophore Modeling, Virtual Screening and Docking Studies

AMP-activated protein kinase: the current landscape for drug development

Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators.

Natural AMPK Activators in Cardiovascular Disease Prevention

Targeting of AMP-activated protein kinase: prospects for computer-aided drug design

Promise and challenges for direct small molecule AMPK activators

Discovery of Novel Dual Adenosine A1/A2A Receptor Antagonists Using Deep Learning, Pharmacophore Modeling and Molecular Docking.

Structure-function analysis of the AMPK activator SC4 and identification of a potent pan AMPK activator

Drug Design Targeting the AMPK Signalling Pathway with Herbal Medicines for Atherosclerosis Therapy

Imidazo[1,2‐a]pyridine Derivatives as AMPK Activators: Synthesis, Structure–Activity Relationships, and Regulation of Reactive Oxygen Species in Renal Fibroblasts

Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products